Christian Kurzeder

ORCID: 0000-0002-9362-3033
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Breast Implant and Reconstruction
  • Breast Lesions and Carcinomas
  • BRCA gene mutations in cancer
  • Endometrial and Cervical Cancer Treatments
  • Cancer Cells and Metastasis
  • HER2/EGFR in Cancer Research
  • Cancer Genomics and Diagnostics
  • Cancer Treatment and Pharmacology
  • Genetic factors in colorectal cancer
  • Bone health and treatments
  • Oral and Maxillofacial Pathology
  • Clinical practice guidelines implementation
  • Single-cell and spatial transcriptomics
  • Pancreatic and Hepatic Oncology Research
  • Reconstructive Surgery and Microvascular Techniques
  • Cancer survivorship and care
  • Immunotherapy and Immune Responses
  • Estrogen and related hormone effects
  • Advanced Breast Cancer Therapies
  • Economic and Financial Impacts of Cancer
  • Cancer and Skin Lesions
  • Uterine Myomas and Treatments
  • Cervical Cancer and HPV Research
  • Lymphoma Diagnosis and Treatment

Breast Center
2017-2025

University of Basel
2017-2025

University Hospital of Basel
2018-2025

ETH Zurich
2021

Women's Hospital
2020

Universitäts Frauenklinik
2003-2019

Ospedale San Giovanni Bellinzona
2015

Kliniken Essen-Mitte
2011-2014

Universität Ulm
2004-2011

Essen University Hospital
2011

The ability of circulating tumor cells (CTCs) to form clusters has been linked increased metastatic potential. Yet biological features and vulnerabilities CTC remain largely unknown. Here, we profile the DNA methylation landscape single CTCs from breast cancer patients mouse models on a genome-wide scale. We find that binding sites for stemness- proliferation-associated transcription factors are specifically hypomethylated in clusters, including OCT4, NANOG, SOX2, SIN3A, paralleling...

10.1016/j.cell.2018.11.046 article EN cc-by-nc-nd Cell 2019-01-01
Anja Irmisch Ximena Bonilla Stéphane Chevrier Kjong-Van Lehmann Franziska Singer and 95 more Nora C. Toussaint Cinzia Esposito Julien Mena Emanuela S. Milani Ruben Casanova Daniel J. Stekhoven Rebekka Wegmann Francis Jacob Bettina Sobottka Sandra Goetze Jack Kuipers Jacobo Sarabia del Castillo Michael Prummer Mustafa A. Tuncel Ulrike Menzel Alice K. Jacobs Stefanie Engler Sujana Sivapatham Anja Frei Gabriele Gut Joanna Ficek Nicola Miglino Rudolf Aebersold Marina Bacac Niko Beerenwinkel Christian Beisel Bernd Bodenmiller Reinhard Dummer Viola Heinzelmann‐Schwarz Viktor H. Koelzer Markus G. Manz Holger Moch Lucas Pelkmans Berend Snijder Alexandre Theocharides Markus Tolnay Andreas Wicki Bernd Wollscheid Gunnar Rätsch Mitchell P. Levesque Melike Ak Faisal Alquaddoomi Jonas Albinus Ilaria Alborelli Sonali Andani Per-Olof Attinger Daniel Baumhoer Beatrice Beck‐Schimmer Lara Bernasconi Anne Bertolini Natalia Chicherova Maya D’Costa Esther Danenberg Natalie R. Davidson Monica-Andreea Drăgan Martin Erkens Katja Eschbach André Fedier Pedro Ferreira Bruno S. Frey Linda Grob Detlef Günther Martina Haberecker Pirmin Haeuptle Sylvia Herter René Holtackers Tamara Huesser Tim M. Jaeger Katharina Jahn Alva Rani James Philip Jermann André Kahles Abdullah Kahraman Werner Kuebler Christian P. Kunze Christian Kurzeder Sebastian Lugert Gerd Maass Philipp Markolin Julian M. Metzler Simone Muenst Riccardo Murri Charlotte K.Y. Ng Stefan Nicolet Marta Nowak Patrick G. A. Pedrioli Salvatore Piscuoglio Mathilde Ritter Christian Rommel María L. Rosano-González Natascha Santacroce Ramona Schlenker Petra Schwalie Severin Schwan Tobias Schär

10.1016/j.ccell.2021.01.004 article EN publisher-specific-oa Cancer Cell 2021-01-21

The aim of that study was to analyze the impact German-S3-breast cancer guideline adherence on clinical outcomes.A retrospective analyzed 3976 patients first diagnosed with primary breast according an S3-guideline-based model classified retrospectively into groups receiving "guideline-adherent and "guideline non-adherent" therapy.There a significant association between treatment prolonged recurrence free overall survival (p = 0.0001). greater number violations in adherence, lower Advanced...

10.1016/j.breast.2009.12.006 article EN cc-by-nc-nd The Breast 2010-02-02

Complete lymph node removal through conventional axillary dissection (ALND) has been standard treatment for breast cancer patients almost a century. In the 1990s, however, and in parallel with advent of sentinel (SLN) procedure, ALND came under increasing scrutiny due to its association significant patient morbidity. Several studies have since provided evidence suggest omission ALND, often favor radiation, selected clinically node-negative, SLN-positive patients, thus supporting current...

10.1186/s13063-018-3021-9 article EN cc-by Trials 2018-12-01
William P. Weber Jane Shaw Andrea L. Pusic Lynda Wyld Monica Morrow and 86 more Tari A. King Zoltán Mátrai Jörg Heil Florian Fitzal Shelley Potter Isabel T. Rubio Maria João Cardoso Oreste ­Gentilini Viviana Galimberti Virgilio Sacchini Emiel J. Rutgers John R. Benson Tanir M. Allweis Martin Haug Régis Resende Paulinelli Tibor Kovács Yves Harder Bahadır M. Gūllūoḡlu Eduardo González Andreé Faridi Elisabeth Elder Peter Dubsky Jens‐Uwe Blohmer Vesna Bjelic‐Radisic Mitchel Barry Susanne Dieroff Hay Kimberly Bowles James French Roland Reitsamer Rupert Koller Peter Schrenk Daniela Kauer-Dorner Jorge Villanova Biazús Fabrício Brenelli Jaime Letzkus Ramon Saccilotto Sarianna Joukainen Susanna Kauhanen Ulla Karhunen‐Enckell Juergen Hoffmann Ulrich Kneser Thorsten Kühn Michalis Kontos Ekaterini Christina Tampaki Moshe Carmon Tal Hadar Giuseppe Catanuto Carlos A. Garcia‐Etienne Linetta B. Koppert Pedro Gouveia Jesper Lagergren Tor Svensjö Nadia Maggi Elisabeth A. Kappos Fabienne D. Schwab Liliana Castrezana Daniel Steffens Janna Krol Christoph Tausch Andreas R. Günthert Michael Knauer Maria C. Katapodi Susanne Bucher Nik Hauser Christian Kurzeder Rosine Mucklow Pelagia G. Tsoutsou Atakan Sezer Güldeniz Karadeniz Çakmak Hasan Karanlık Patricia Fairbrother László Romics Giacomo Montagna Cı́cero de Andrade Urban Melanie Walker Silvia Formenti Guenther Gruber Frank Zimmermann Daniel R. Zwahlen Sherko Küemmel Mahmoud El‐Tamer Marie Jeanne Vrancken Peeters Orit Kaidar‐Person Michael Gnant Philip Poortmans Jana de Boniface

Demand for nipple- and skin- sparing mastectomy (NSM/SSM) with immediate breast reconstruction (BR) has increased at the same time as indications post-mastectomy radiation therapy (PMRT) have broadened. The aim of Oncoplastic Breast Consortium initiative was to address relevant questions arising this clinically challenging scenario.A large global panel oncologic, oncoplastic reconstructive surgeons, patient advocates oncologists developed recommendations clinical practice in an iterative...

10.1016/j.breast.2022.03.008 article EN The Breast 2022-03-18

ABSTRACT The binding of the viral major glycoprotein BLLF1 (gp350/220) to CD21 cellular receptor is thought play an essential role during infection B lymphocytes by Epstein-Barr virus (EBV). However, since CD21-negative cells have been reported be infectible with EBV, additional interactions between and molecules seem probable. Based on a recombinant genomic EBV plasmid, we deleted gene that encodes BLLF1. We tested ability mutant infect different lymphoid epithelial cell lines. Primary...

10.1128/jvi.74.21.10142-10152.2000 article EN Journal of Virology 2000-11-01
Maud Kamal Sonia Lameiras Marc Deloger Adeline Morel Sophie Vacher and 95 more Charlotte Lecerf Célia Dupain Emmanuelle Jeannot Elodie Girard Sylvain Baulande Coraline Dubot Gemma G. Kenter Ekaterina S. Jordanova Els M.J.J. Berns Guillaume Bataillon Marina Popović Roman Rouzier Wulfran Cacheux Christophe Le Tourneau Alain Nicolas Nicolas Servant Suzy Scholl Ivan Bièche Anne de la Rochefordière P. Fumoleau Aljoša Mandić Nina Samet Choumouss Kamoun Windy Rondoff Sébastien Armanet Alexandra Rohel Souhir Neffati Marie‐Emmanuelle Legrier Sinette Ngoumou Mabiala Sylvain Dureau Coralie Errera Marius Craina Mădălin-Marius Margan Sanne Samuels Henry Zijlmans Peter Hillemanns Sorin Dema Alis Dema Goran Malenković Branislav Djuran Anne Floquet Frédéric Guyon Pierre Colombo Michel Fabbro Christine Kerr Charlotte Ngô Fabrice Lécuru Eleonor Rivin del Campo Charles Coutant Frédéric Marchal Nathalie Mesgouez-Nebout Virginie Fourchotte Jean Guillaume Féron Philippe Morice Éric Deutsch Pauline Wimberger Jean-Marc Classe Heiko von der Leyen Mathieu Minsat I Nagy Balázs Bálint Nicolas de Saint-Jorre Alexia Savignoni Franck Perez Patricia Tresca Noreen Gleeson Philippe Hupé Sergio Román-Román Emmanuel Barillot Fanny Coffin Bastiaan Nuijen Alexandre Boissonnas Marc Billaud Laurence Lafanéchère Jaap Verweij Arjan Bandel Jozien Hellemann Kirsten Ruigrok-Ritstier Philipp Harter Christian Kurzeder Alexander Mustea Eugéniu Banu Elisabeta Patcas Victor Cernat Andrea Slocker Michele Mondini Maud Bossard Julie Chupin Sjoerd Rodenhuis René H. Medema Anika Havemeier Thomas Fink Amelie Michon Christine Kubiak Corine M. Beaufort

Cervical cancer (CC) remains a leading cause of gynaecological cancer-related mortality with infection by human papilloma virus (HPV) being the most important risk factor. We analysed association between different viral integration signatures, clinical parameters and outcome in pre-treated CCs. Different signatures were identified using HPV double capture followed next-generation sequencing (NGS) 272 CC patients from BioRAIDs study [NCT02428842]. Correlations clinical, biological molecular...

10.1038/s41416-020-01153-4 article EN cc-by British Journal of Cancer 2020-11-16
Arthur Dondi Ulrike Lischetti Francis Jacob Franziska Singer Nico Borgsmüller and 95 more Ricardo Coelho Rudolf Aebersold Melike Ak Faisal Alquaddoomi Silvana I. Albert Jonas Albinus Ilaria Alborelli Sonali Andani Per-Olof Attinger Marina Bacac Daniel Baumhoer Beatrice Beck‐Schimmer Christian Beisel Lara Bernasconi Anne Bertolini Bernd Bodenmiller Ximena Bonilla Lars Bosshard Byron Calgua Ruben Casanova Stéphane Chevrier Natalia Chicherova Maya D’Costa Esther Danenberg Natalie J. Davidson Monica-Andreea Drăgan Reinhard Dummer Stefanie Engler Martin Erkens Katja Eschbach Cinzia Esposito André Fedier Pedro Ferreira Joanna Ficek Anja Frei Bruno S. Frey Sandra Goetze Linda Grob Gabriele Gut Detlef Günther Martina Haberecker Pirmin Haeuptle Sylvia Herter René Holtackers Tamara Huesser Alexander Immer Anja Irmisch Alice K. Jacobs Tim M. Jaeger Katharina Jahn Alva Rani James Philip Jermann André Kahles Abdullah Kahraman Viktor H. Koelzer Werner Kuebler Jack Kuipers Christian P. Kunze Christian Kurzeder Kjong-Van Lehmann Mitchell Levesque Ulrike Lischetti Sebastian Lugert Gerd Maass Markus G. Manz Philipp Markolin Martin Mehnert Julien Mena Julian M. Metzler Nicola Miglino Emanuela S. Milani Holger Moch Simone Muenst Riccardo Murri Charlotte K.Y. Ng Stefan Nicolet Marta Nowak Mónica Núñez López Patrick G. A. Pedrioli Lucas Pelkmans Salvatore Piscuoglio Michael Prummer Natalie Rimmer Mathilde Ritter Christian Rommel María L. Rosano-González Gunnar Rätsch Natascha Santacroce Jacobo Sarabia del Castillo Ramona Schlenker Petra Schwalie Severin Schwan Tobias Schär Gabriela Senti Wenguang Shao

Understanding the complex background of cancer requires genotype-phenotype information in single-cell resolution. Here, we perform long-read RNA sequencing (scRNA-seq) on clinical samples from three ovarian patients presenting with omental metastasis and increase PacBio depth to 12,000 reads per cell. Our approach captures 152,000 isoforms, which over 52,000 were not previously reported. Isoform-level analysis accounting for non-coding isoforms reveals 20% overestimation protein-coding gene...

10.1038/s41467-023-43387-9 article EN cc-by Nature Communications 2023-11-27

Breast, colorectal, ovarian, and endometrial cancers constitute approximately 30% of newly diagnosed cancer cases in Switzerland, affecting more than 12,000 individuals annually. Hundreds these patients are likely to carry germline pathogenic variants associated with hereditary breast ovarian (HBOC) or Lynch syndrome (LS). Genetic services (counseling testing) for susceptibility can prevent many diagnoses deaths through early identification risk management.Cascade screening is the systematic...

10.2196/resprot.8138 article EN cc-by JMIR Research Protocols 2017-09-20
Bettina Sobottka Marta Nowak Anja Frei Martina Haberecker Samuel Merki and 95 more Mitchell P. Levesque Reinhard Dummer H. Moch Viktor H. Koelzer Rudolf Aebersold Melike Ak Faisal Alquaddoomi Jonas Albinus Ilaria Alborelli Sonali Andani Per-Olof Attinger Marina Bacac Daniel Baumhoer Beatrice Beck‐Schimmer Niko Beerenwinkel Christian Beisel Lara Bernasconi Anne Bertolini Bernd Bodenmiller Ximena Bonilla Ruben Casanova Stéphane Chevrier Natalia Chicherova Maya D’Costa Esther Danenberg Natalie J. Davidson Monica-Andreea Drăganmoch Stefanie Engler Martin Erkens Katja Eschbach Cinzia Esposito André Fedier Pedro Ferreira Joanna Ficek Bruno S. Frey Sandra Goetze Linda Grob Gabriele Gut Detlef Günther Martina Haberecker Pirmin Haeuptle Viola Heinzelmann‐Schwarz Sylvia Herter René Holtackers Tamara Huesser Anja Irmisch Francis Jacob Alice K. Jacobs Tim M. Jaeger Katharina Jahn Alva Rani James Philip Jermann André Kahles Abdullah Kahraman Werner Kuebler Jack Kuipers Christian P. Kunze Christian Kurzeder Kjong-Van Lehmann Sebastian Lugert Gerd Maass Markus G. Manz Philipp Markolin Julien Mena Ulrike Menzel Julian M. Metzler Nicola Miglino Emanuela S. Milani Simone Muenst Riccardo Murri Charlotte K.Y. Ng Stefan Nicolet Patrick G. A. Pedrioli Lucas Pelkmans Salvatore Piscuoglio Michael Prummer Mathilde Ritter Christian Rommel María L. Rosano-González Gunnar Rätsch Natascha Santacroce Jacobo Sarabia del Castillo Ramona Schlenker Petra Schwalie Severin Schwan Tobias Schär Gabriela Senti Franziska Singer Sujana Sivapatham Berend Snijder Vipin T. Sreedharan Stefan G. Stark Daniel J. Stekhoven Alexandre Theocharides Tinu M. Thomas

CD8+ tumor-infiltrating T cells can be regarded as one of the most relevant predictive biomarkers in immune-oncology. Highly infiltrated tumors, referred to inflamed (clinically "hot"), show favorable response immune checkpoint inhibitors contrast tumors with a scarce infiltrate called desert or excluded "cold"). Nevertheless, quantitative and reproducible methods examining their prevalence within are lacking. We therefore established computational diagnostic algorithm quantitatively measure...

10.1038/s41374-021-00653-y article EN cc-by Laboratory Investigation 2021-08-26

The presence of circulating tumor cells (CTCs) in patients with breast cancer correlates to a bad prognosis. Yet, CTCs are detectable only minority progressive cancer, and factors that influence the abundance remain elusive. We conducted CTC isolation enumeration selected group 73 consecutive characterized by invasive high load treatment discontinuation at time isolation. were quantified Parsortix microfluidic device. Clinicopathological variables, blood counts detailed history prior...

10.1186/s13058-018-1067-y article EN cc-by Breast Cancer Research 2018-11-20

Summary. Conventional metaphase cytogenetics underestimates the frequency of specific chromosome aberrations in B‐cell chronic lymphocytic leukaemia (B‐CLL) as a result very low proliferative activity these cells vitro . New molecular approaches, such fluorescence situ hybridization (FISH) or comparative genomic (CGH), may circumvent this problem, at least part, but techniques are either strongly dependent on knowledge candidate regions detect only unbalanced aberrations. In present study,...

10.1046/j.1365-2141.2002.03719.x article EN British Journal of Haematology 2002-08-29

Recombinant adeno-associated virus (AAV) is a promising non-pathogenic vector in the emerging field of gene therapy. For AAV serotype 2 (AAV-2) infection, experimental evidence points to an involvement heparan sulphate proteoglycans (HSPG), but also existence additional receptors. We investigated potential role tetraspanin CD9 AAV-2 infection breast cancer cells mainly because it binds heparin-binding EGF-like growth factor, suggesting that may interact with virus. Among cell lines,...

10.3892/ijmm.19.2.325 article EN International Journal of Molecular Medicine 2007-02-01
Coming Soon ...